<qa>  How many eligible patients will be randomly assigned to Arm A?Approximately 600 eligible patients will be randomly assigned in a 1:1 ratio to either Arm A tesetaxel plus a reduced dose of capecitabine or Arm B approved dose of capecitabine alone. 